Coronavirus disease 2019 in an orthotopic liver transplant recipient living with human immunodeficiency virus
© 2020 Wiley Periodicals LLC..
Coronavirus disease 2019 (COVID-19), mediated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can manifest with flu-like illness and severe pneumonia with acute respiratory distress syndrome (ARDS). Immunocompromised patients merit particular attention as altered host immunity may influence both disease severity and duration of viral shedding as is described with several other ribonucleic acid respiratory viruses. Yet immunocompromised status alone, in the absence of other comorbidities, may not necessarily predict severe illness presentations and poorer clinical outcomes as indicated by recent reports of COVID-19-infected solid organ transplant recipients and people living with human immunodeficiency virus (HIV). Such patients may even be spared the robust inflammatory response that precipitates ARDS associated with COVID-19, complicating the management of iatrogenic immunosuppression in this setting. We present a case of an orthotopic liver transplant recipient with well-controlled HIV who successfully recovered from a mild, flu-like illness attributed to SARS-CoV-2.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
Transplant infectious disease : an official journal of the Transplantation Society - 22(2020), 5 vom: 14. Okt., Seite e13351 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Modi, Anita R [VerfasserIn] |
---|
Links: |
---|
Themen: |
4QWG6N8QKH |
---|
Anmerkungen: |
Date Completed 15.12.2020 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/tid.13351 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM310802393 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM310802393 | ||
003 | DE-627 | ||
005 | 20231225140858.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/tid.13351 |2 doi | |
028 | 5 | 2 | |a pubmed24n1035.xml |
035 | |a (DE-627)NLM310802393 | ||
035 | |a (NLM)32500666 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Modi, Anita R |e verfasserin |4 aut | |
245 | 1 | 0 | |a Coronavirus disease 2019 in an orthotopic liver transplant recipient living with human immunodeficiency virus |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.12.2020 | ||
500 | |a Date Revised 07.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 Wiley Periodicals LLC. | ||
520 | |a Coronavirus disease 2019 (COVID-19), mediated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can manifest with flu-like illness and severe pneumonia with acute respiratory distress syndrome (ARDS). Immunocompromised patients merit particular attention as altered host immunity may influence both disease severity and duration of viral shedding as is described with several other ribonucleic acid respiratory viruses. Yet immunocompromised status alone, in the absence of other comorbidities, may not necessarily predict severe illness presentations and poorer clinical outcomes as indicated by recent reports of COVID-19-infected solid organ transplant recipients and people living with human immunodeficiency virus (HIV). Such patients may even be spared the robust inflammatory response that precipitates ARDS associated with COVID-19, complicating the management of iatrogenic immunosuppression in this setting. We present a case of an orthotopic liver transplant recipient with well-controlled HIV who successfully recovered from a mild, flu-like illness attributed to SARS-CoV-2 | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a HIV | |
650 | 4 | |a hydroxychloroquine | |
650 | 4 | |a immunocompromised | |
650 | 4 | |a orthotopic liver transplantation | |
650 | 7 | |a Anti-HIV Agents |2 NLM | |
650 | 7 | |a Immunosuppressive Agents |2 NLM | |
650 | 7 | |a Hydroxychloroquine |2 NLM | |
650 | 7 | |a 4QWG6N8QKH |2 NLM | |
650 | 7 | |a Prednisone |2 NLM | |
650 | 7 | |a VB0R961HZT |2 NLM | |
700 | 1 | |a Koval, Christine E |e verfasserin |4 aut | |
700 | 1 | |a Taege, Alan J |e verfasserin |4 aut | |
700 | 1 | |a Modaresi Esfeh, Jamak |e verfasserin |4 aut | |
700 | 1 | |a Eghtesad, Bijan |e verfasserin |4 aut | |
700 | 1 | |a Narayanan Menon, K V |e verfasserin |4 aut | |
700 | 1 | |a Quintini, Cristiano |e verfasserin |4 aut | |
700 | 1 | |a Miller, Charles |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Transplant infectious disease : an official journal of the Transplantation Society |d 1999 |g 22(2020), 5 vom: 14. Okt., Seite e13351 |w (DE-627)NLM113005482 |x 1399-3062 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2020 |g number:5 |g day:14 |g month:10 |g pages:e13351 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/tid.13351 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 22 |j 2020 |e 5 |b 14 |c 10 |h e13351 |